Skip to content
About Us
Management Team
Board of Directors
Scientific & Clinical Advisors
Pipeline
Pimavanserin
AGN XX/YY
AC-262271
Other Programs
Scientific Publications
Technology
Partnering
Investors
Corporate Governance
Stock Information
Press Releases
Event Calendar
SEC Filings
Analyst Coverage
Annual Report and Proxy
Information Request
E-mail Alerts
News
Careers
Job Postings
Benefits
Recruiters
Contact Us
Directions
Investors
Corporate Governance
Stock Information
Press Releases
Event Calendar
SEC Filings
Analyst Coverage
Annual Report and Proxy
Information Request
E-mail Alerts
Home
»
Investor Relations
» Annual Report and Proxy
Annual Report and Proxy
2010 Proxy Statement
2009 Annual Report
2009 Proxy Statement
2008 Annual Report
2008 Proxy Statement
2007 Annual Report
2007 Proxy Statement
2006 Annual Report
2006 Proxy Statement
2005 Annual Report
2005 Proxy Statement
2004 Annual Report
back to top